Marie-Andrée GAMACHE joins Pierre Fabre Laboratories as CEO of the Medical Care

Castres (France), March 31, 2025 – Pierre Fabre Laboratories has announced the appointment of Marie-Andrée Gamache as Chief Executive Officer (CEO) of its Medical Care. In this capacity, Marie-Andrée Gamache joins the Group’s Executive Committee and reports to Eric Ducournau, Group CEO. 

A Canadian national, Marie-Andrée Gamache has spent over 25 years in the pharmaceutical industry, in a wide range of leadership roles at country, regional and global levels across Europe, North America, Asia, Middle East and Africa. She holds a proven track record of broad leadership and P&L experience, with expertise from early pipeline to commercialization.

Before joining Pierre Fabre, Marie-Andrée was Country President and Managing Director for Novartis UK and Ireland. Previously, she had rejoined Novartis in 2019 as Head of the Oncology division for the Middle East and Africa region, after spending four years at Merck KGAA as Managing Director in Belgium and Sub-Sahara Africa

Marie-Andrée Gamache will bring her energetic leadership, international stature and wide pharmaceutical experience to Pierre Fabre Medical Care. In 2024, the latter achieved revenues of 1,3 billion euros spread across oncology (39%), dermatology (15%), primary care (26%) and family health care (13%). Marie-Andrée’s main priorities will be to fuel the strong momentum of the oncology portfolio through expansion to new indications and territories, to optimize revenue and profitability growth for the balance of the Medical Care portfolio, and to prepare for the next decade by supervising the R&D pipeline development in targeted oncology, medical dermatology and rare diseases.